Search

Your search keyword '"Herms, Jochen"' showing total 298 results

Search Constraints

Start Over You searched for: Author "Herms, Jochen" Remove constraint Author: "Herms, Jochen" Database Unpaywall Remove constraint Database: Unpaywall
298 results on '"Herms, Jochen"'

Search Results

1. Neuronal and oligodendroglial but not astroglial tau translates to in vivo tau-PET signals in primary tauopathies

3. Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation

5. Validity and value of metabolic connectivity in mouse models of β-amyloid and tauopathy

9. Lethal Borna disease virus 1 (BoDV-1) infections of humans and animals – in-depth molecular epidemiology and phylogeography

10. CTNI-31. TREATMENT BENEFIT IN PATIENTS AGED 80 YEARS OR OLDER WITH BIOPSY-PROVEN AND NON-RESECTED GLIOBLASTOMA IS DEPENDENT ON MGMT PROMOTER METHYLATION STATUS

11. Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution

12. Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages

13. Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH–Wild-Type Glioblastoma

15. Plasma extracellular vesicle Tau isoform ratios and TDP-43 inform about molecular pathology in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

16. Targeting the glycine-rich domain of TDP-43 with antibodies prevents its aggregation in vitro and reduces neurofilament levels in vivo

18. Long-Term Pioglitazone Treatment Has No Significant Impact on Microglial Activation and Tau Pathology in P301S Mice

19. Treatment benefit in patients aged 80 years or older with biopsy-proven and non-resected glioblastoma is dependent on MGMT promoter methylation status

20. Epigenetic Association Analyses and Risk Prediction of RLS

22. Update on quality assurance in neuropathology: Summary of the round robin trials on TERT promoter mutation, H3-3A mutation, 1p/19q codeletion, and KIAA1549::BRAF fusion testing in Germany in 2020 and 2021

23. Long-Term Pioglitazone Treatment Has No Significant Impact on Microglial Activation and Tau Pathology in P301S Mice

29. [18F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data

31. A deep learning-based histopathology classifier for Focal Cortical Dysplasia

32. Depletion and activation of microglia impact metabolic connectivity of the mouse brain

33. Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution

35. Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [18F]UCB-H PET imaging

36. Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein

37. [18F]DED PET Imaging of Reactive Astrogliosis in Neurodegenerative Diseases: Preclinical Proof of Concept and First-in-Human Data

38. Clinical and genetic features of Lewy body pathology in autosomal dominant and sporadic Alzheimer disease

40. Alterations inPTPN11and other RAS-/MAP-Kinase pathway genes define ganglioglioma with adverse clinical outcome and atypic histopathological features

41. TSPO PET signal using [18F]GE180 is associated with survival in recurrent gliomas

42. NIMG-26. UPTAKE OF [18F]GE-180 IN TSPO PET IS ASSOCIATED WITH SURVIVAL IN PATIENTS WITH RECURRENT GLIOMA

43. Combination of pre-treatment dynamic [18F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma

44. TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome

45. Single-nucleus chromatin accessibility profiling highlights distinct astrocyte signatures in progressive supranuclear palsy and corticobasal degeneration

46. Multiple tumorous lesions of the pituitary gland

47. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study

48. Improved pasireotide response in USP8 mutant corticotroph tumours in vitro

50. A multiplex pedigree with pathologically confirmed multiple system atrophy and Parkinson’s disease with dementia

Catalog

Books, media, physical & digital resources